Journal of Urologic Oncology

Editorial

November 30, 2023

Summarizing the Intentions and Outcomes of JUO 2023 Issue 3

Cheol Kwak

J Urol Oncol. 2023;21(3):181-182.

Invited Review

November 30, 2023

Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma

Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.

J Urol Oncol. 2023;21(3):183-199.

The purpose of this review is to provide an up-to-date understanding of the literature describing the impact of body composition on renal cell carcinoma (RCC) prognosis and outcomes. Although obesity...

Topic Article

November 30, 2023

Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis

Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.

J Urol Oncol. 2023;21(3):200-207.

Purpose: This study investigated the effects of preoperative renal artery embolization (PRAE) before radical nephrectomy (RN) for advanced nonmetastatic renal cell carcinoma (RCC) on perioperative and oncologic outcomes. Materials and Methods:...

Invited Review

November 30, 2023

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects

Hyerim Ha, Joo Han Lim

J Urol Oncol. 2023;21(3):208-216.

Renal cell carcinoma (RCC) remains a significant challenge in oncology, prompting thorough investigations into adjuvant treatments aimed at enhancing both survival and quality of life for patients. In this review,...

Invited Review

November 30, 2023

Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type

Chan Woo Wee, Jaeho Cho

J Urol Oncol. 2023;21(3):217-227.

Renal cell carcinoma (RCC) has traditionally been considered one of the most radioresistant tumors based on in vitro and clinical studies that utilized a low biologically effective dose. However, recent...

Invited Review

November 30, 2023

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023

Jiwoong Yu, Hyun Hwan Sung

J Urol Oncol. 2023;21(3):228-240.

Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer (NMIBC) poses a significant clinical challenge, prompting a need for effective treatment options. Although radical cystectomy is a standard approach, it is burdened by...

Topic Article

November 30, 2023

Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer

Chung Un Lee, Wan Song, Minyong Kang, et al.

J Urol Oncol. 2023;21(3):241-248.

Purpose: Radical cystectomy (RC) is recommended for patients with non–muscle-invasive bladder cancer (NMIBC) who are unresponsive to intravesical bacillus Calmette-Guérin (BCG) instillation. However, RC is a very risky treatment, and...

Original Article

November 30, 2023

Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy

Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.

J Urol Oncol. 2023;21(3):249-256.

Purpose: The efficacy of standard chemotherapy or radical cystectomy in patients who have urothelial tumors with variant histology (VH) is very limited in terms of their prognosis. This study aimed...

Topic Article

November 30, 2023

Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer

Jaeyoung Cho, Jungyo Suh, Dalsan You, et al.

J Urol Oncol. 2023;21(3):257-263.

Purpose: This study aimed to identify predictive factors for the response to abiraterone in patients with high-risk metastatic hormone-sensitive prostate cancer (mHSPC). Materials and Methods: This study analyzed the clinical characteristics...

Topic Article

November 30, 2023

Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy

Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, et al.

J Urol Oncol. 2023;21(3):264-270.

Purpose: In present, the use of androgen receptor targeting agents (ARTA) is one of the standard treatments for metastatic castration-resistant prostate cancer (mCRPC) without previous chemotherapy. However, some patients may...

Original Article

November 30, 2023

Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel

Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, et al.

J Urol Oncol. 2023;21(3):271-276.

Purpose: We propose a new potential marker of progression-free survival (PFS) called negative delta-prostate-specific antigen (PSA) time ratio (NDPSATR) and compare it with conventional PSA response, defined as PSA decline...

Erratum: Addition of the second author

November 30, 2023

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer

Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, et al.

J Urol Oncol. 2023;21(3):277-277.

Current Issue: Volume 21(3); Nov 2023

Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer (4,314 times) Je-Gun Joung, Joo-Young Park, So-Yun Yang, et al. Korean J Urol Oncol. 2021;19(2):101-108. Cited By 1 Review Article May 31, 2021 Full text PubReader ePub PDF	Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer (4,174 times) Jaemin Jo, Sanghoon Han, Jung-Sik Huh Korean J Urol Oncol. 2021;19(1):23-29. Cited By 1 Review Article Feb 26, 2021 Full text PubReader ePub PDF
The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment (4,010 times) Da Som Choi, Su Jeong Kang, In Ho Chang, et al. Korean J Urol Oncol. 2021;19(1):30-39. Review Article Feb 26, 2021 Full text PubReader ePub PDF	Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2 (3,981 times) Amit Ghose, Makarand Khochikar, Ravindra Sabnis, et al. Korean J Urol Oncol. 2021;19(1):1-15. Review Article Feb 26, 2021 Full text PubReader ePub PDF
Laparoscopic Radical Cystectomy With Intracorporeal Orthotopic Neobladder Reconstruction: An Initial Experience of Modified Studer Reconstruction Techniques (3,942 times) Jeong Ho Kim Korean J Urol Oncol. 2021;19(2):117-123. Case Report May 31, 2021 Full text PubReader ePub PDF	Patient-Specific Tumor Microenvironment Models (3,851 times) Jung Woo Lee, Jia Kim, Youngjae Shin, et al. Korean J Urol Oncol. 2021;19(4):197-222.Correction in: J Urol Oncol 2022;20(1):69 Review Article Nov 25, 2021 Full text PubReader ePub PDF
Clinical Implications of Urinary Microbiome in Bladder Cancer (3,312 times) Jae Hun Shim, Joon Hee Gook, In Ho Chang, et al. Korean J Urol Oncol. 2021;19(2):71-78. Review Article May 31, 2021 Full text PubReader ePub PDF	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer (3,284 times) Jaewoon Jeong, Jae Baek Ha, In Ho Chang Korean J Urol Oncol. 2022;20(1):12-24. Review Article Feb 24, 2022 Full text PubReader ePub PDF
Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide (3,219 times) Dong Hyeon An, Hwiwoo Kim, Donghyun Lee, et al. Korean J Urol Oncol. 2021;19(1):60-69. Original Article Feb 26, 2021 Full text PubReader ePub PDF	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer (3,187 times) Jae Young Joung, Sung Han Kim Korean J Urol Oncol. 2022;20(1):1-11. Cited By 1 Review Article Feb 24, 2022 Full text PubReader ePub PDF
The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer (3,118 times) Sung Han Kim, Done-Eun Lee, Ho Kyung Seo, et al. Korean J Urol Oncol. 2021;19(1):48-59. Original Article Feb 26, 2021 Full text PubReader ePub PDF Supplementary Material	The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model (3,048 times) Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, et al. Korean J Urol Oncol. 2021;19(1):40-47. Cited By 1 Original Article Feb 26, 2021 Full text PubReader ePub PDF
Coffee Consumption and Risk of Prostate Cancer in Local, Advanced, and Fatal Grades: A Meta-Epidemiological Study of Prospective Cohort Studies (2,995 times) Jong-Myon Bae Korean J Urol Oncol. 2021;19(1):16-22. Review Article Feb 26, 2021 Full text PubReader ePub PDF	Microbiome of Genitourinary Tumors: Especially in Prostate Cancer and Kidney Cancer (2,958 times) Kyungchan Min, Seok Joong Yun, Hansoo Park, et al. Korean J Urol Oncol. 2021;19(3):136-147. Review Article Aug 31, 2021 Full text PubReader ePub PDF
An Update of Gonadotropin-Releasing Hormone Antagonists in the Treatment of Advanced Prostate Cancer (2,947 times) Jeong Hee Hong Korean J Urol Oncol. 2021;19(2):79-91. Review Article May 31, 2021 Full text PubReader ePub PDF	Predictive Factors for Acute Urinary Retention After Transperineal Template-Guided Mapping Biopsy (2,869 times) Si Hyun Sung, Chung Un Lee, Jae Hoon Chung, et al. Korean J Urol Oncol. 2021;19(3):148-154. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF
Construction of a Retrospective Cohort to Observe 10-Year Urologic Cancer Treatment Trends at the Biggest Medical Center of South Korea (2,834 times) Se Young Choi, Ho Heon Kim, Bumjin Lim, et al. Korean J Urol Oncol. 2021;19(4):232-243. Original Article Nov 25, 2021 Full text PubReader ePub PDF	Usefulness of Prostate-Specific Antigen Density as an Indicator for Recommending Prebiopsy Magnetic Resonance Imaging to Prevent Missed Prostate Cancer Diagnoses (2,772 times) Jin Hyung Jeon, Kyo Chul Koo, Byung Ha Chung, et al. Korean J Urol Oncol. 2021;19(3):155-163. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF
Investigation of Information Acquisition Channel for Prostate Cancer High-Risk Group (2,765 times) Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al. Korean J Urol Oncol. 2021;19(3):174-182. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF Supplementary Material	Predictive Factors of De Novo Overactive Bladder After Radical Prostatectomy in Patients With Clinically Localized Prostate Cancer: A Prospective Observational Study (2,709 times) Jun Nyung Lee, Sang Won Kim, Kyeong-Hyeon Byeon, et al. Korean J Urol Oncol. 2021;19(2):109-116. Cited By 1 Original Article May 31, 2021 Full text PubReader ePub PDF
Machine Learning Techniques in Prostate Cancer Diagnosis According to Prostate-Specific Antigen Levels and Prostate Cancer Gene 3 Score (2,655 times) Roberto Passera, Stefano De Luca, Cristian Fiori, et al. Korean J Urol Oncol. 2021;19(3):164-173. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF	Gastric Leiomyoma Misdiagnosed as a Left Cystic Adrenal Tumor (2,567 times) Young-Joo Kim Korean J Urol Oncol. 2021;19(3):193-196. Case Report Aug 31, 2021 Full text PubReader ePub PDF
The Present and Future of Intravesical Therapy in Bladder Cancer (2,551 times) Sin-Woo Seong, Youngjae Shin, In Ho Chang, et al. Korean J Urol Oncol. 2022;20(2):82-91. Review Article May 26, 2022 Full text PubReader ePub PDF	Utility of Urinalysis as a Follow-up Surveillance Tool in Nonmuscle Invasive Bladder Cancer (2,483 times) Minuk Park, Bumjin Lim, Dalsan You, et al. Korean J Urol Oncol. 2021;19(4):244-251. Original Article Nov 25, 2021 Full text PubReader ePub PDF
Percutaneous Renal Tumor Biopsy in Small Renal Masses (2,480 times) Heejo Yang, Kihong Kim, Younsoo Jeon Korean J Urol Oncol. 2021;19(2):92-100. Review Article May 31, 2021 Full text PubReader ePub PDF	Risk Factors Leading to Radical Cystectomy in Patients Who Had Undergone Nephroureterectomy (2,480 times) Janghui Lee, Bumjin Lim, Dalsan You, et al. Korean J Urol Oncol. 2021;19(4):271-280. Original Article Nov 25, 2021 Full text PubReader ePub PDF
Perioperative and Oncological Outcomes of 1,002 Consecutive Patients With Localized Renal Cell Carcinoma Treated by Robotic Partial Nephrectomy at a Single Center (2,428 times) Taejin Kim, Jae Hoon Chung, Hyun Hwan Sung, et al. Korean J Urol Oncol. 2021;19(3):183-192. Original Article Aug 31, 2021 Full text PubReader ePub PDF	Recurrent Bleeding From Ileal Conduit Stomal Varices in a Patient With Portal Hypertension (2,323 times) Jae-Wook Chung, Yun-Sok Ha, Jun Nyung Lee, et al. Korean J Urol Oncol. 2021;19(2):124-126. Case Report May 31, 2021 Full text PubReader ePub PDF
Subcutaneous Interleukin-2 Monotherapy for Metastatic Renal Cell Carcinoma in Korean Patients (2,259 times) Jeong Ho Kim, Ki Soo Lee, Choung-Soo Kim, et al. Korean J Urol Oncol. 2021;19(4):252-260. Original Article Nov 25, 2021 Full text PubReader ePub PDF	Small Renal Mass Biopsy: When to Do? (2,233 times) Jin Seon Cho Korean J Urol Oncol. 2021;19(3):129-135. Review Article Aug 31, 2021 Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

Cited By 2	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 2	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 1	Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer
Cited By 1	The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model

4,314	Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer
4,174	Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer
4,010	The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment
3,981	Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2
3,942	Laparoscopic Radical Cystectomy With Intracorporeal Orthotopic Neobladder Reconstruction: An Initial Experience of Modified Studer Reconstruction Techniques